Dyne Therapeutics, Inc.DYNNASDAQ
LOADING
|||
EPS Growth Accelerating
Trending higher, above historical average, structural decline.
Left:
||||
Year-over-year earnings per share growth rate
Latest
14.68%
↑ 105% above average
Average (9y)
-285.34%
Historical baseline
Range
High:175.47%
Low:-2502.50%
CAGR
-24.1%
Structural decline
| Period | Value |
|---|---|
| 2024 | 14.68% |
| 2023 | -22.29% |
| 2022 | -10.24% |
| 2021 | -136.29% |
| 2020 | -313.33% |
| 2019 | 36.17% |
| 2018 | -200.00% |
| 2017 | 104.89% |
| 2016 | -2502.50% |
| 2015 | 175.47% |